19 results
SC TO-T/A
EX-99
KNTE
Kinnate Biopharma Inc
19 Mar 24
Third party tender offer statement (amended)
4:44pm
, terminate, amend or modify any collective bargaining agreement, Company Benefit Plan (or plan or arrangement that would be a Company Benefit Plan
SC TO-T
EX-99
KNTE
Kinnate Biopharma Inc
4 Mar 24
Third party tender offer statement
5:24pm
as in effect on the Agreement Date, (i) adopt, enter into, establish, terminate, amend or modify any collective bargaining agreement, Company Benefit Plan
8-K
EX-2.1
KNTE
Kinnate Biopharma Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:10am
of any Company Benefit Plan as in effect on the Agreement Date, (i) adopt, enter into, establish, terminate, amend or modify any collective bargaining agreement … , in each case as would give rise to liability under applicable Environmental Laws.
Section 4.16 Labor Relations.
(a) There are no collective
8-K
EX-3.1
KNTE
Kinnate Biopharma Inc
28 Jul 23
Amendments to Articles of Incorporation or Bylaws
4:06pm
principal competitor of the Company (in each case, including, without limitation, any employment agreement, collective bargaining agreement or consulting
S-3ASR
EX-1.2
74nh52hw6lpak6p82i
3 Jan 22
Automatic shelf registration
8:51am
10-K
138 l4664hmbr
29 Mar 21
Annual report
4:26pm
8-K
EX-3.2
bb3l6
8 Dec 20
Kinnate Biopharma Announces Closing of Initial Public Offering
12:00am
424B4
sp56b d7s
3 Dec 20
Prospectus supplement with pricing info
4:48pm
S-1/A
EX-1.1
ver624
30 Nov 20
IPO registration (amended)
6:05am
S-1/A
mio6c43m
30 Nov 20
IPO registration (amended)
6:05am
S-1
clb9jr9
13 Nov 20
IPO registration
5:03pm
S-1
EX-3.4
vuek1 xbjzo70j2d4
13 Nov 20
IPO registration
5:03pm
DRS/A
4pjr236omwzjypl
3 Nov 20
Draft registration statement (amended)
12:00am
DRS/A
f5j 4bx6elhyv40
16 Oct 20
Draft registration statement (amended)
12:00am
DRS
hpkmet
4 Sep 20
Draft registration statement
12:00am
- Prev
- 1
- Next